is jardiance a glp-1 (empagliflozin): Uses, Side Effects, Alternatives & More jardiance vs glp 1 💉

The CV benefits extend to the promising effects in improving HF outcomes

In August 2025, the FDA approved semaglutide to treat MASH with moderate to advanced liver fibrosis

Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study

doi: 10.1007/s11064-008-9646-4 28 AnFMChenSXuZYinLWangYLiuARet al

1 Pharmacological treatments such as thiazolidinediones, sulfonylureas, and insulins have major drawbacks, including hypoglycaemia and weight gain

Both medications can have serious side effects, including pancreatitis and allergic reactions, though these are not common